Literature DB >> 4116745

Polymyositis and penicillamine.

P L Schraeder, H A Peters, D S Dahl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4116745     DOI： 10.1001/archneur.1972.00490170088013

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  14 in total

1.  Association of myasthenia gravis and polymyositis with neoplasia, infection and autoimmune disorders.

Authors:  W M Behan; P O Behan; D Doyle
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

Review 2.  Antirheumatic drugs: clinical pharmacology and therapeutic use.

Authors:  G L Craig; W W Buchanan
Journal:  Drugs       Date:  1980-12       Impact factor: 9.546

Review 3.  Induction of auto-immune syndromes by penicillamine therapy in rheumatoid arthritis and other diseases.

Authors:  I A Jaffe
Journal:  Springer Semin Immunopathol       Date:  1981

4.  Therapeutic quandary: asymptomatic primary biliary cirrhosis associated with polymyositis.

Authors:  R A Willson
Journal:  Dig Dis Sci       Date:  1981-04       Impact factor: 3.199

5.  D-penicillamine induced polymyositis causing complete heart block.

Authors:  G D Wright; C Wilson; A L Bell
Journal:  Clin Rheumatol       Date:  1994-03       Impact factor: 2.980

Review 6.  Experimental autoallergic myositis, polymyositis and myasthenia gravis. Autoimmune muscle disease associated with immunodeficiency and neoplasia.

Authors:  R L Dawkins
Journal:  Clin Exp Immunol       Date:  1975-08       Impact factor: 4.330

7.  [Myasthenic syndrome during penicillamine treatment (author's transl)].

Authors:  F Schumm; M Stöhr
Journal:  Klin Wochenschr       Date:  1978-02-01

8.  Polymyositis complicating D-penicillamine treatment.

Authors:  A O Aydintug; R Cervera; D D'Cruz; G Ramírez; R A Asherson; M A Khamashta; G R Hughes
Journal:  Postgrad Med J       Date:  1991-11       Impact factor: 2.401

Review 9.  Remission-inducing drugs in rheumatoid arthritis.

Authors:  T P Anastassiades
Journal:  Can Med Assoc J       Date:  1980-02-23       Impact factor: 8.262

Review 10.  Ocular myasthenia gravis after D-penicillamine administration.

Authors:  L J Katz; R L Lesser; J R Merikangas; J P Silverman
Journal:  Br J Ophthalmol       Date:  1989-12       Impact factor: 4.638
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.